207 related articles for article (PubMed ID: 28694965)
1. Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.
Pontillo C; Mischak H
Clin Kidney J; 2017 Apr; 10(2):192-201. PubMed ID: 28694965
[TBL] [Abstract][Full Text] [Related]
2. Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.
Critselis E; Lambers Heerspink H
Nephrol Dial Transplant; 2016 Feb; 31(2):249-54. PubMed ID: 25791724
[TBL] [Abstract][Full Text] [Related]
3. Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.
Rodríguez-Ortiz ME; Pontillo C; Rodríguez M; Zürbig P; Mischak H; Ortiz A
Sci Rep; 2018 Oct; 8(1):15940. PubMed ID: 30374033
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion.
Critselis E; Vlahou A; Stel VS; Morton RL
Nephrol Dial Transplant; 2018 Mar; 33(3):441-449. PubMed ID: 29106632
[TBL] [Abstract][Full Text] [Related]
5. CKD273, a new proteomics classifier assessing CKD and its prognosis.
Argilés Á; Siwy J; Duranton F; Gayrard N; Dakna M; Lundin U; Osaba L; Delles C; Mourad G; Weinberger KM; Mischak H
PLoS One; 2013; 8(5):e62837. PubMed ID: 23690958
[TBL] [Abstract][Full Text] [Related]
6. A urinary proteome-based classifier for the early detection of decline in glomerular filtration.
Pontillo C; Jacobs L; Staessen JA; Schanstra JP; Rossing P; Heerspink HJL; Siwy J; Mullen W; Vlahou A; Mischak H; Vanholder R; Zürbig P; Jankowski J
Nephrol Dial Transplant; 2017 Sep; 32(9):1510-1516. PubMed ID: 27387473
[TBL] [Abstract][Full Text] [Related]
7. The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease.
Verbeke F; Siwy J; Van Biesen W; Mischak H; Pletinck A; Schepers E; Neirynck N; Magalhães P; Pejchinovski M; Pontillo C; Lichtinghagen R; Brand K; Vlahou A; De Bacquer D; Glorieux G
Nephrol Dial Transplant; 2021 Apr; 36(5):811-818. PubMed ID: 31837226
[TBL] [Abstract][Full Text] [Related]
8. The long path towards implementation of clinical proteomics: Exemplified based on CKD273.
Nkuipou-Kenfack E; Zürbig P; Mischak H
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019083
[TBL] [Abstract][Full Text] [Related]
9. Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.
Siwy J; Schanstra JP; Argiles A; Bakker SJ; Beige J; Boucek P; Brand K; Delles C; Duranton F; Fernandez-Fernandez B; Jankowski ML; Al Khatib M; Kunt T; Lajer M; Lichtinghagen R; Lindhardt M; Maahs DM; Mischak H; Mullen W; Navis G; Noutsou M; Ortiz A; Persson F; Petrie JR; Roob JM; Rossing P; Ruggenenti P; Rychlik I; Serra AL; Snell-Bergeon J; Spasovski G; Stojceva-Taneva O; Trillini M; von der Leyen H; Winklhofer-Roob BM; Zürbig P; Jankowski J
Nephrol Dial Transplant; 2014 Aug; 29(8):1563-70. PubMed ID: 24589724
[TBL] [Abstract][Full Text] [Related]
10. Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients.
Rambabova-Bushljetik I; Metzger J; Siwy J; Dohcev S; Bushljetikj O; Filipce V; Trajceska L; Mischak H; Spasovski G
Nephrol Dial Transplant; 2022 Sep; 37(10):2014-2021. PubMed ID: 34634117
[TBL] [Abstract][Full Text] [Related]
11. Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
Currie GE; von Scholten BJ; Mary S; Flores Guerrero JL; Lindhardt M; Reinhard H; Jacobsen PK; Mullen W; Parving HH; Mischak H; Rossing P; Delles C
Cardiovasc Diabetol; 2018 Apr; 17(1):50. PubMed ID: 29625564
[TBL] [Abstract][Full Text] [Related]
12. Urinary Proteomics as a Tool to Identify Kidney Responders to Dipeptidyl Peptidase-4 Inhibition: A Hypothesis-Generating Analysis from the MARLINA-T2D Trial.
Siwy J; Klein T; Rosler M; von Eynatten M
Proteomics Clin Appl; 2019 Mar; 13(2):e1800144. PubMed ID: 30632692
[TBL] [Abstract][Full Text] [Related]
13. Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases.
Filip S; Pontillo C; Peter Schanstra J; Vlahou A; Mischak H; Klein J
Expert Rev Proteomics; 2014 Oct; 11(5):535-48. PubMed ID: 24957818
[TBL] [Abstract][Full Text] [Related]
14. Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension.
Lindhardt M; Persson F; Oxlund C; Jacobsen IA; Zürbig P; Mischak H; Rossing P; Heerspink HJL
Nephrol Dial Transplant; 2018 Feb; 33(2):296-303. PubMed ID: 28064163
[TBL] [Abstract][Full Text] [Related]
15. Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.
Lindhardt M; Persson F; Currie G; Pontillo C; Beige J; Delles C; von der Leyen H; Mischak H; Navis G; Noutsou M; Ortiz A; Ruggenenti PL; Rychlik I; Spasovski G; Rossing P
BMJ Open; 2016 Mar; 6(3):e010310. PubMed ID: 26936907
[TBL] [Abstract][Full Text] [Related]
16. Urinary peptidome analyses for the diagnosis of chronic kidney disease in dogs.
Pelander L; Brunchault V; Buffin-Meyer B; Klein J; Breuil B; Zürbig P; Magalhães P; Mullen W; Elliott J; Syme H; Schanstra JP; Häggström J; Ljungvall I
Vet J; 2019 Jul; 249():73-79. PubMed ID: 31239169
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review.
Catanese L; Siwy J; Mischak H; Wendt R; Beige J; Rupprecht H
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298105
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.
Tofte N; Lindhardt M; Adamova K; Beige J; Beulens JWJ; Birkenfeld AL; Currie G; Delles C; Dimos I; Francová L; Frimodt-Møller M; Girman P; Göke R; Havrdova T; Kooy A; Mischak H; Navis G; Nijpels G; Noutsou M; Ortiz A; Parvanova A; Persson F; Ruggenenti PL; Rutters F; Rychlík I; Spasovski G; Speeckaert M; Trillini M; von der Leyen H; Rossing P
Diabet Med; 2018 Oct; 35(10):1375-1382. PubMed ID: 29781558
[TBL] [Abstract][Full Text] [Related]
19. Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?
Magalhães P; Pejchinovski M; Markoska K; Banasik M; Klinger M; Švec-Billá D; Rychlík I; Rroji M; Restivo A; Capasso G; Bob F; Schiller A; Ortiz A; Perez-Gomez MV; Cannata P; Sanchez-Niño MD; Naumovic R; Brkovic V; Polenakovic M; Mullen W; Vlahou A; Zürbig P; Pape L; Ferrario F; Denis C; Spasovski G; Mischak H; Schanstra JP
Sci Rep; 2017 Dec; 7(1):16915. PubMed ID: 29208969
[TBL] [Abstract][Full Text] [Related]
20. Urinary peptidomic biomarkers of renal function in heart transplant recipients.
Huang QF; Zhang ZY; Van Keer J; Trenson S; Nkuipou-Kenfack E; Yang WY; Thijs L; Vanhaecke J; Van Aelst LNL; Van Cleemput J; Janssens S; Verhamme P; Mischak H; Staessen JA
Nephrol Dial Transplant; 2019 Aug; 34(8):1336-1343. PubMed ID: 29982668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
